Revolutionizing Diabetes Treatment with Electricity? Automatically Activating When Blood Sugar Rises — Electronic Implant Emerges in Diabetes Research

Diet, exercise, medication, and insulin injections. When people hear about diabetes treatment, these methods often come to mind.

In the future, a "small electronic device inside the body" might be added to that list.

A research team from ETH Zurich has developed an implantable system that uses electricity to convert glucose into another substance. In experiments with mice with type 2 diabetes accompanied by obesity, not only was a reduction in blood sugar levels observed, but also weight loss.

The research findings were published in the scientific journal "Science" and also featured in the German newspaper WELT.

However, there is a key point to note first. The results presented are from laboratory and mouse experiments. The effectiveness and safety as a treatment for humans have not been established.

Even with that premise, it is an intriguing study in terms of how electronic technology can be incorporated into blood sugar management.

It's not about "curing with electrical stimulation," but chemically altering sugar

The device is named "ECHO," officially known as "Electrocatalytic Closed-Loop Health Optimization," a system combining electrocatalytic reactions with automatic control.

The expression "lowering blood sugar with electricity" might conjure up images of stimulating the body to release insulin from the pancreas. However, the core mechanism this time is different.

The device converts glucose into "gluconate." By excreting the product through the kidneys into the urine, it aims to reduce excess sugar.

This reaction is facilitated by a catalyst that combines fine gold structures on graphite felt with tiny platinum particles. When an electric current is applied, a chemical reaction progresses on its surface.

A notable feature is that the central part of the reaction does not use living cells or enzymes. It attempts to act directly on the sugar itself, differing from drugs that instruct the body's functions.

An automatic control system that operates only when blood sugar is high

Even if sugar can be reduced, it is not always good to keep reducing it. Excessive lowering of blood sugar is also dangerous.

Therefore, the research team combined glucose sensors with smartphone-based control.

The sensor measures the glucose concentration in the fluid filling the tissues. This information is sent to a smartphone, and when it exceeds a set value, the catalyst is activated. It stops when it reaches the target.

This is a so-called "closed-loop control" that reflects the measured results in the next action.

The novelty here is not just in reducing sugar. It lies in starting and stopping reactions with electronic devices and trying to adjust the necessary amount.

However, "automatic stop design" and "preventing hypoglycemia under all real-life conditions" are not the same. The reliability of measurement and control will also be a subject for future verification.

Improvement in blood sugar in about an hour, weight loss in six weeks

In the study, they first examined whether sugar conversion was possible using a liquid containing 5 liters of glucose. This amount roughly corresponds to the blood volume in humans.

Furthermore, tests were conducted on mice with obesity and type 2 diabetes. According to the abstract of the paper, by operating the device at low voltage, blood sugar homeostasis was restored within about an hour.

In the six-week experiment, while body weight and triglycerides decreased, free fatty acids and ketone bodies in the blood increased. It was reported that a shift occurred from sugar metabolism to fat metabolism.

According to the attached article, the automatic control linking sensors and smartphones was tested for 12 days. It is necessary to understand separately the six-week evaluation of the device and the trial period of automatic control.

During the research period, no detectable hypoglycemia or obvious inflammatory or behavioral adverse effects were reported. However, this alone does not prove the safety of long-term use.

Reasons not to simply rejoice over weight loss

Lower blood sugar and weight loss. Just from the headline, the device might seem to solve two problems simultaneously.

However, without confirming the metabolic changes that occurred along with the weight change, the value as a treatment cannot be assessed.

Particularly noteworthy is the increase in ketone bodies. Ketone bodies are produced in the process of breaking down fat for energy. The mere fact of an increase does not immediately mean a dangerous state.

On the other hand, in people with severe insulin deficiency, excessive accumulation of ketone bodies can lead to "ketoacidosis," where the blood becomes acidic.

Experts introduced by WELT pointed out that while ketoacidosis was not observed in mice, it is unknown whether it can be used safely in humans in the same way.

Weight loss is both a promising result and a reason to investigate what is happening inside the body in detail.

Even if blood sugar decreases, the role of insulin does not disappear

Another easily confused point is "lowering blood sugar" versus "resolving the causes or pathologies of diabetes."

The device this time does not supplement the lack of insulin. It is not a study that demonstrated improvement in insulin resistance by itself.

According to expert opinions submitted to the Science Media Center Germany, there are differing views on future target patients. While some experts consider the possibility of broad applications, others are cautious, considering factors like insulin deficiency and kidney function, suggesting the target may be limited.

It is crucial not to take this study as "evidence that insulin will become unnecessary." Especially for type 1 diabetes, it does not show that insulin can be replaced.

At present, this study does not provide grounds for changing ongoing medication or insulin treatments.

Barriers to overcome for human application

The amount of sugar that needs to be processed differs significantly between humans and mice.

The ability of the catalyst to work depends on the surface area of the electrodes, but in humans, both body size and blood volume increase. Therefore, it is still unclear how large the device needs to be or if multiple devices will be necessary to achieve sufficient effect.

Even if the reaction can be confirmed with 5 liters of liquid, this alone does not demonstrate practicality within the human body. In the human body, the supply and consumption of sugar continuously change according to diet and activity.

Moreover, issues such as infection during implantation, catalyst performance over long-term use, device replacement frequency, and malfunctions of sensors or control systems also need to be considered.

What patients want to know is not just "can sugar be converted?" but also "how many years can it be used?", "does replacement require surgery?", and "will the burden of daily life be reduced?".

Only by answering these questions can an experimental device come closer to being a treatment option.

Sharing on social media and readers' voices—questions beyond expectations

On social media, sharing of related articles about this research was confirmed in health-related communities on Reddit, among others. However, based on the information confirmed this time, the content of the comments could not be verified, and the overall approval or reaction trend of social media users cannot be determined.

On the other hand, reader comments on the WELT article showed both expectations and cautious opinions. Below is a summary of their content in Japanese.

Posts wishing for the success of the research expressed expectations for technology to lighten the burden of living with diabetes, such as daily measurements and injections. There are also opinions welcoming the advancement of medical devices and urging support for their development.

Another post expressed concern that even promising ideas might take time to gain approval and mass production. However, the years to practical use written by readers are predictions and not schedules indicated by the developers.

There was also a comment questioning whether simply reducing sugar in the blood could solve the problems of diabetes. It raised doubts about the difference between sugar utilization in cells and lowering blood sugar levels.

These are not medical evaluations per se, but they well reflect the readers' interest. Alongside expectations for new technology, questions are being asked such as "how will it change my life?" and "can it truly replace necessary treatments?".

The next research Japanese readers should focus on

When reading the results of this study, what should be noted is not the grand phrase "a future without drugs," but what the next verification will reveal.

Does it have the processing capacity to accommodate human body size? Can safety be maintained with long-term use? Which patients will benefit, and who will it not be suitable for? How will the burden and cost compare to existing treatments?

It is not yet at a stage where the timing of introduction in Japan or insurance coverage can be foreseen.

Nevertheless, the idea of combining electronic devices that measure sugar concentration with those that convert sugar holds potential. To what extent can the burden of blood sugar management be entrusted to machines in the future? As research to expand those options, we should watch the future verification closely.

Sources and References

1. WELT: Introduction of the device's mechanism, animal experiments, and expert evaluations.
   https://www.welt.de/wissenschaft/article6adf0fa6ba080c37bf6d1aac/diabetes-forscher-senken-blutzucker-mit-strom-und-machen-eine-erstaunliche-entdeckung.html

2. ETH Zurich: Announcement by the research institution. Confirmation of catalyst structure, linkage with sensors, experiment overview, and untested status in humans.
   https://ethz.ch/en/news-and-events/eth-news/news/2026/10/tackling-diabetes-with-an-electronic-implant.htmlETH Zurich

3. Original Paper: Maity et al. "Wireless electrocatalytic closed-loop system for drug-free management of diabesity." Confirmation of approximately 1-hour blood sugar improvement and 6-week metabolic changes in the published abstract.
   https://doi.org/10.1126/science.ady8560
   https://www.research-collection.ethz.ch/items/033e418e-3d87-4a6f-ad06-81fbabb5f07eresearch-collection.ethz.ch

4. Science Media Center Germany: Expert evaluations of the research. Confirmation of target patients, the point that insulin cannot be replaced, and remaining challenges for human application.
   https://www.sciencemediacenter.de/angebote/implantat-senkt-blutzuckerspiegel-in-mausstudie-26260sciencemediacenter.de

5. Reddit: Shared articles related to the research. Confirmation of the existence of posts and introductions in search results. Not used as evidence to indicate the content of comments or trends in approval or disapproval.
   https://www.reddit.com/r/Health/comments/1xedxvl/this_implant_zaps_away_high_blood_sugar_in_mice/
   https://www.reddit.com/r/UpliftingNews/comments/1xee0hr/this_implant_zaps_away_high_blood_sugar_in_mice/